SCHEMBL286638

SCHEMBL286638

CC(C)(C)c1cc(CCCOC(N)=O)cc(C(C)(C)C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.54
TNKS2 Q9H2K2 1/20 0.38
RXRA P19793 2/20 0.38
RXRB P28702 2/20 0.38
RXRG P48443 2/20 0.38
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
TLR4 O00206 3/20 0.37
CD14 P08571 3/20 0.37
LY96 Q9Y6Y9 3/20 0.37
HMGCR P04035 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1789827 0.87 TNKS2 (0.40) LMNATNKS2RXRARXRBRXRG
SCHEMBL1789826 0.85 RXRA (0.42) LMNATNKS2RXRARXRBRXRG
SCHEMBL1787886 0.81 HDAC3 (0.40) TNKS2RXRARXRBRXRGHDAC3
SCHEMBL14672764 0.80 RXRA (0.45) LMNARXRARXRBRXRGHDAC3
SCHEMBL1282261 0.80 GABRA1 (0.43) LMNARXRARXRBRXRGHMGCR
SCHEMBL1787882 0.79 RXRA (0.40) LMNATNKS2RXRARXRBRXRG
SCHEMBL669629 0.78 LMNA (0.59) LMNATNKS2TSHRCYP2C19NPC1
SCHEMBL2370063 0.77 LMNA (0.54) LMNATNKS2NPC1RECQLRAB9A
SCHEMBL1788871 0.76 RXRB (0.41) RXRARXRBRXRGHDAC3HDAC4
SCHEMBL1788868 0.75 RXRB (0.44) RXRARXRBRXRGHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026107134-A1 USE OF SMALL MOLECULE GLUTAMINASE INHIBITORS FOR TREATING AGE-RELATED DISORDERS LEAL THERAPEUTICS, INC. (US) 2026-05-21 WO disclosed
EP-4734976-A2 AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS RyCarma Therapeutics, Inc. (US) 2026-05-06 EP disclosed
EP-4724418-A1 TRICINE AND CITRIC ACID-BASED CATIONIC LIPIDS Sanofi (FR) 2026-04-15 EP disclosed
EP-4724080-A2 STAPLED PEPTIDES AND METHODS THEREOF Parabilis Medicines, Inc. (US) 2026-04-15 EP disclosed
EP-4642434-A2 LIPID COMPOSITIONS ON THE BASIS OF IONIZABLE LIPIDS, USE FOR DELIVERY TO IMMUNE CELLS Life Technologies Corporation (US) 2025-11-05 EP disclosed
WO-2025151449-A1 BIFUNCTIONAL P53-BINDING COMPOUNDS AND USES THEREOF PHOTYS THERAPEUTICS, INC. (US) 2025-07-17 WO disclosed
WO-2025104706-A2 SMALL MOLECULE MODULATORS OF MAS AND MRGD RECEPTORS XITRA THERAPEUTICS GMBH (DE) 2025-05-22 WO disclosed
WO-2025072886-A9 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2025-05-15 WO disclosed
EP-4543990-A1 INDOCYANINE GREEN (ICG) MODIFICATION FOR TREATMENT OF LIVER CANCER The Children's Medical Center Corporation (US) 2025-04-30 EP disclosed
WO-2025054361-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2025-03-13 WO disclosed
WO-2009026444-A1 RYANODINE CHANNEL BINDERS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2009-02-26 WO disclosed
WO-2008144507-A2 SPIROOXINDOLE INHIBITORS OF AURORA KINASE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2008-11-27 WO disclosed
WO-2008127361-A2 SYNTHESIS OF ENONE INTERMEDIATE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2008-10-23 WO disclosed
WO-2008121767-A2 STITCHED POLYPEPTIDES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2008-10-09 WO disclosed
WO-2008119015-A2 SYNTHESIS OF THIOHYDANTOINS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2008-10-02 WO disclosed
WO-2008063300-A2 BORONIC ACIDS AND ESTERS AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2008-05-29 WO disclosed
WO-2006124902-A2 SYNTHESIS OF SALINOSPORAMIDE A AND ANALOGUES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2006-11-23 WO disclosed
WO-2006113615-A2 ANTI-MICROBIAL AGENTS AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2006-10-26 WO disclosed
EP-0970066-A1 AMINOEPOXIDES FROM AMINOALDEHYDES AND IN-SITU FORMED HALOMETHYL ORGANOMETALLIC REAGENT G.D. SEARLE & CO. (US) 2000-01-12 EP disclosed
WO-1998029401-A1 AMINOEPOXIDES FROM AMINOALDEHYDES AND IN-SITU FORMED HALOMETHYL ORGANOMETALLIC REAGENT G.D. SEARLE & CO. (US) 1998-07-09 WO disclosed